» Articles » PMID: 34496482

Effects of Oleuropein on Epirubicin and Cyclophosphamide Combination Treatment in Rats

Overview
Specialty Pharmacology
Date 2021 Sep 9
PMID 34496482
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Oleuropein is the main bioactive polyphenolic compound in olive leaves, olive, and olive oil. Its anticancer, antioxidant, and antiinflammatory effects have been proven through several and studies. This study aimed to explore the effects of oleuropein on cyclophosphamideand epirubicin-induced toxicity in female rats.

Materials And Methods: Seven groups containing eight rats in each group were formed. Four cycles of 16 mg/kg/week of cyclophosphamide and 2.5 mg/kg/week of epirubicin were administered to the rats through intraperitoneal injection. Oleuropein (150 mg/kg/week) was simultaneously applied via oral gavage. The effects of oleuropein were examined with hemogram tests in whole blood samples and biochemical analysis in serum samples. Interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) in the serum samples were analyzed through enzyme-linked immunosorbent assay. Subsequently, a comet assay was performed using lymphocyte DNA. The levels of oxidant [i.e., malondialdehyde (MDA)] and antioxidants [i.e., catalase (CAT), glutathione (GSH), and superoxide dismutase (SOD)] were measured in the heart, kidney, and liver tissues.

Results: Oleuropein could reduce DNA damage and serum TNF-α and IL-6 levels. It also ameliorated some hemogram and biochemical parameters that deteriorated due to antineoplastic drugs. It increased the amounts of antioxidants (GSH, SOD, and CAT) and reduced the level of MDA in the heart, kidney, and liver tissues.

Conclusion: Oleuropein might be a beneficial agent against toxicity caused by the combination treatment of cyclophosphamide and epirubicin. Further studies should be performed to demonstrate the protective effects of oleuropein against antineoplastic induced-toxicity precisely.

Citing Articles

Magnolin alleviates cyclophosphamide-induced oxidative stress, inflammation, and apoptosis via signaling pathway.

Ince S, Demirel H, Demirkapi E, Kucukkurt I, Eryavuz A, Arslan-Acaroz D Toxicol Res (Camb). 2024; 13(4):tfae129.

PMID: 39148957 PMC: 11323662. DOI: 10.1093/toxres/tfae129.


Boswellic Acid and Betulinic Acid Pre-treatments Can Prevent the Nephrotoxicity Caused by Cyclophosphamide Induction.

Berkoz M, Ciftci O Dokl Biochem Biophys. 2024; 517(1):115-126.

PMID: 38744737 DOI: 10.1134/S1607672924600234.


Use of Oleuropein and Hydroxytyrosol for Cancer Prevention and Treatment: Considerations about How Bioavailability and Metabolism Impact Their Adoption in Clinical Routine.

Gervasi F, Pojero F Biomedicines. 2024; 12(3).

PMID: 38540115 PMC: 10968586. DOI: 10.3390/biomedicines12030502.


Cardioprotective effect of oleuropein in a cisplatin-induced cardiotoxicity model in rats.

Gokcek I Naunyn Schmiedebergs Arch Pharmacol. 2023; 397(5):3403-3410.

PMID: 37955692 DOI: 10.1007/s00210-023-02828-4.


Effects of Oleuropein and Hydroxytyrosol on Inflammatory Mediators: Consequences on Inflammaging.

Pojero F, Aiello A, Gervasi F, Caruso C, Ligotti M, Calabro A Int J Mol Sci. 2023; 24(1).

PMID: 36613822 PMC: 9820525. DOI: 10.3390/ijms24010380.

References
1.
Kalaiselvan I, Dicson S, Kasi P . Olive oil and its phenolic constituent tyrosol attenuates dioxin-induced toxicity in peripheral blood mononuclear cells via an antioxidant-dependent mechanism. Nat Prod Res. 2014; 29(22):2129-32. DOI: 10.1080/14786419.2014.989393. View

2.
Alirezaei M, Rezaei M, Hajighahramani S, Sookhtehzari A, Kiani K . Oleuropein attenuates cognitive dysfunction and oxidative stress induced by some anesthetic drugs in the hippocampal area of rats. J Physiol Sci. 2016; 67(1):131-139. PMC: 10717304. DOI: 10.1007/s12576-016-0446-3. View

3.
Ryu S, Choi H, Yoon K, Lee O, Kim K, Lee B . Oleuropein suppresses LPS-induced inflammatory responses in RAW 264.7 cell and zebrafish. J Agric Food Chem. 2015; 63(7):2098-105. DOI: 10.1021/jf505894b. View

4.
Andreadou I, Mikros E, Ioannidis K, Sigala F, Naka K, Kostidis S . Oleuropein prevents doxorubicin-induced cardiomyopathy interfering with signaling molecules and cardiomyocyte metabolism. J Mol Cell Cardiol. 2014; 69:4-16. DOI: 10.1016/j.yjmcc.2014.01.007. View

5.
Kurauchi K, Nishikawa T, Miyahara E, Okamoto Y, Kawano Y . Role of metabolites of cyclophosphamide in cardiotoxicity. BMC Res Notes. 2017; 10(1):406. PMC: 5557551. DOI: 10.1186/s13104-017-2726-2. View